Delaware Prescription Monitoring Program



Welcome to the Delaware Prescription Monitoring Program (PMP). The PMP is an electronic tool that collects information on ALL controlled substance prescriptions, schedules II-V. The data is reported on a daily basis by Delaware-licensed pharmacies and prescribers who dispense controlled substances. The website is available 24/7; prescribers and dispensers of controlled substances can register to obtain immediate access to their current or prospective patient’s prescription history report.

The website is to be used for healthcare purposes only. The Delaware Prescription Monitoring Act (16 Del. C. § 4798) authorizes the Office of Controlled Substances (OCS) to establish, maintain and monitor the PMP and to reduce misuse of controlled substances
in this State while promoting improved professional practice and patient care.

The Office of Controlled Substances does not warrant any report to be accurate or fully complete and expressly disclaims liability for errors and omissions in the contents of this report. Records on this report should be verified before any clinical decisions are
made or actions are taken. For more information about any prescription in a PMP report or to verify a prescription, please contact the dispensing practitioner or pharmacy.


HIPPA WARNING

HIPAA and all confidentiality and non-disclosure provisions of Delaware Law cover the information contained in this database. All users must comply with HIPPA Privacy Rule Requirements when using this system and inappropriate access or disclosure of this information is a felony under Delaware Law and may result in criminal prosecution.

Reports from the PMP database may not be distributed to the patient. Patients may request their own PMP records directly from the Delaware Division of Professional Regulation.

For additional information and questions, please e-mail the Delaware Prescription Monitoring Program at delawarepmp@state.de.us .

FAILURE TO ABIDE BY ALL APPLICABLE FEDERAL HIPPA AND STATE PRIVACY LAWS
COULD LEAD TO DISCIPLINARY SANCTIONS, WHICH MAY INCLUDE FINES AND/OR CRIMINAL PROSECUTION

 
 
 
 


© 2012 Health Information Designs, Inc. All rights reserved.

Office of Controlled Substances

861 Silver Lake Blvd.

Suite 203 | Dover, DE 19904